Call for screening for primary aldosteronism: an underdiagnosed and treatable disease
Journal
Journal of thoracic disease
Journal Volume
10
Journal Issue
2
Pages
557
Date Issued
2018-02
Author(s)
Abstract
Recent studies have raised the important issue of prevalence and underdiagnosed of primary aldosteronism (PA) in primary care setting. The crucial role of a correct diagnosis of PA is demonstrated by current studies that aldosterone over-secretion is not only resulted in cardiovascular and renal damage (1,2) but also associated with adverse metabolic complication, including insulin resistance, type 2 diabetes mellitus, and osteoporosis (3-5). Monticone null et al . had addressed the issue that PA is a frequent cause of secondary hypertension even in the general hypertensive population and indicates that the majority of hypertensive patients should be screened for PA (6).
SDGs
Other Subjects
aldosterone; renin; aldosterone release; aldosterone renin ratio; analytical parameters; clinical outcome; cost benefit analysis; disease association; disease severity; early diagnosis; Editorial; human; morbidity; mortality; outcome assessment; practice guideline; prevalence; primary hyperaldosteronism; screening; tertiary care center
Publisher
AME PUBL CO